Skip to content

Author

Lixia Chen

We have 3 of 51 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

The molecular basis of ADP-ribose pyrophosphorylation by a phage PRPS-like enzyme in NAD+ reconstitution

Abstract Depletion of cellular NAD+ is an increasingly recognized bacterial antiphage strategy, and many phages counter this pressure by rebuilding NAD+ from its cleavage products. In the NARP1 pathway, Adps converts ADP-ribose (ADPR) and ATP into ADPR-PP, the immediate substrate for Namat-dependent NAD+ synthesis, but...

Meng-Xi Liu, Jing-Bo Ma, Qing-Qing Zhang et al. · 0 citations
Review Sep 2026

Comprehensive insights into Astragalus membranaceus polysaccharides: Extraction, structural characteristics, bioactivities, and applications: A review.

Astragalus membranaceus polysaccharides (APS), bioactive macromolecules derived from the roots of Astragalus membranaceus (Fisch.) Bge., exert immunomodulatory, anti-inflammatory, antioxidant, and metabolic regulatory effects. However, the molecular features and compositional profiles of APS are strongly influenced by...

Jing Cheng, Qian-Hui Liu, Rui Zhu et al. · 0 citations
Aug 2026

Discovery of DCAF16-based PROTACs as SHP2 degraders.

The design and synthesis of SHP2 PROTACs that recruit the DCAF16 E3 ligase for targeted SHP2 degradation are reported that support the potential of SHP2-targeted protein degradation as an alternative strategy to enzymatic inhibition and provide a promising starting point for the further development of SHP2 degraders.

X. Pang, Yuxin Gan, Qing-Yuan Hu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.